{
  "slug": "amneal-pharmaceuticals-inc",
  "name": "Amneal Pharmaceuticals Inc.",
  "description": "Amneal Pharmaceuticals is a global pharmaceutical company focused on providing access to essential and affordable medicines. They develop, manufacture, and distribute a broad portfolio of over 290 high-quality pharmaceuticals, including complex generics, biosimilars, and specialty branded medicines, with a strong commitment to U.S. manufacturing and patient well-being.",
  "url": "https://optimly.ai/brand/amneal-pharmaceuticals-inc",
  "websiteUrl": "https://amneal.com/",
  "logoUrl": "https://logo.clearbit.com/amneal.com",
  "baiScore": 48,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Pharmaceuticals",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:02:44.876Z",
  "verifiedVitals": {
    "website": "https://amneal.com",
    "founded": "2002",
    "headquarters": "Bridgewater, New Jersey, USA",
    "pricing_model": "Focused on affordability and accessibility, implying competitive pricing for its generic and biosimilar portfolio and value-driven pricing for specialty products, aiming to save patients and the healthcare system significant costs.",
    "core_products": "Complex generics, biosimilars (e.g., for fighting cancer), and specialty branded medicines (e.g., CREXONT for Parkinson's disease, Brekiya for migraine and cluster headaches).",
    "key_differentiator": "A broad and diverse portfolio of over 290 medicines spanning generics, biosciences, and specialty categories, a strong commitment to bringing essential medicine manufacturing back to the U.S., and a patient-centric mission focused on access and affordability.",
    "target_markets": "Patients in the U.S. seeking essential and affordable medicines for a wide range of conditions, as well as healthcare providers.",
    "employee_count": "~2,500 U.S. jobs and growing",
    "funding_stage": "Publicly traded (NYSE: AMRX)",
    "subcategory": "Generics, Biosimilars, Specialty Medicines"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional (non-scaled) pharmaceutical development and distribution: Reliance on smaller-scale or less integrated pharmaceutical processes, potentially leading to higher manufacturing costs, reduced ",
      "Contract Manufacturing Organizations (CMOs) or third-party distributors: Outsourcing manufacturing and distribution entirely to external agencies. While potentially cost-effective, it could reduce dir",
      "Continued lack of affordable access to essential medicines: Without companies like Amneal focusing on expanding access and reducing costs for essential medicines, patients, especially those with chron"
    ],
    "solutionIntents": [
      "Amneal Pharmaceuticals products",
      "Amneal Parkinson's disease treatment",
      "Amneal migraine medicine",
      "Amneal manufacturing USA",
      "Amneal careers",
      "Other generic or specialty pharmaceutical companies: Patients and healthcare providers would need to rely solely on the offerings of other established pharmaceutical companies specializing in generics"
    ],
    "evaluationIntents": []
  },
  "businessProfileClaims": [],
  "timestamp": 1786619570210
}